[Characteristics of CD4+T lymphocyte counts changed in antiretroviral-naive and antiretroviral-treated HIV-infected individuals' cohorts in Tianjin].

Q1 Medicine
D H Luo, L T Han, J Y Hou, X T Wu, X Wang, F N Zhao, J Xu
{"title":"[Characteristics of CD4<sup>+</sup>T lymphocyte counts changed in antiretroviral-naive and antiretroviral-treated HIV-infected individuals' cohorts in Tianjin].","authors":"D H Luo, L T Han, J Y Hou, X T Wu, X Wang, F N Zhao, J Xu","doi":"10.3760/cma.j.cn112338-20260521-00371","DOIUrl":null,"url":null,"abstract":"<p><p><b>Objective:</b> To characterize the dynamic changes in CD4<sup>+</sup>T lymphocyte (CD4) counts among HIV-infected individuals in Tianjin, China, under untreated and antiretroviral treatment (ART) conditions, and to provide evidence for optimizing HIV case management and prevention strategies. <b>Methods:</b> The data were derived from the follow-up records of HIV-infected individuals aged 15 and above in Tianjin from 2005 to 2024, obtained from the Chinese Disease Control and Prevention Information System. Records were split into non-ART and ART phases as time-dependent cohorts, with the same HIV-infected individuals contributing to both phases before and after treatment initiation. A continuous-time Markov model was applied to both cohorts to estimate annual transition rates of CD4 counts across immunological categories. In addition, a linear mixed-effects model with natural splines was fitted to the ART cohort to characterize individual recovery trajectories stratified by baseline CD4 count levels. <b>Results:</b> The non-ART cohort and the ART cohort enrolled 709 and 2 865 HIV-infected individuals, respectively. In untreated individuals, CD4 counts declined progressively: annual transition rates from ≥500 to 350-499, 350-499 to 200-349, and 200-349 to <200 cells/μl were 34.8% (95%<i>CI</i>: 30.3%-39.9%), 19.0% (95%<i>CI</i>: 16.1%-22.5%), and 9.3% (95%<i>CI</i>: 6.8%-12.7%), with mean sojourn times of 2.87, 5.25, and 10.73 years, respectively. After ART initiation, CD4 counts recovery followed a nonlinear pattern: transition rates from <200 to 200-349, 200-349 to 350-499, and 350-499 to ≥500 cells/μl were 91.8% (95%<i>CI</i>: 86.6%-97.4%), 63.7% (95%<i>CI</i>: 60.9%-66.6%), and 42.6% (95%<i>CI</i>: 40.9%-44.4%), with corresponding mean sojourn times of 1.09, 1.57, and 2.35 years. <b>Conclusions:</b> CD4 count transition rates in non-ART HIV-infected individuals decreased as immunodeficiency progressed, while post-ART recovery rates varied substantially across CD4 count strata.</p>","PeriodicalId":23968,"journal":{"name":"中华流行病学杂志","volume":"47 10","pages":"1802-1808"},"PeriodicalIF":0.0000,"publicationDate":"2026-10-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"中华流行病学杂志","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3760/cma.j.cn112338-20260521-00371","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

Objective: To characterize the dynamic changes in CD4+T lymphocyte (CD4) counts among HIV-infected individuals in Tianjin, China, under untreated and antiretroviral treatment (ART) conditions, and to provide evidence for optimizing HIV case management and prevention strategies. Methods: The data were derived from the follow-up records of HIV-infected individuals aged 15 and above in Tianjin from 2005 to 2024, obtained from the Chinese Disease Control and Prevention Information System. Records were split into non-ART and ART phases as time-dependent cohorts, with the same HIV-infected individuals contributing to both phases before and after treatment initiation. A continuous-time Markov model was applied to both cohorts to estimate annual transition rates of CD4 counts across immunological categories. In addition, a linear mixed-effects model with natural splines was fitted to the ART cohort to characterize individual recovery trajectories stratified by baseline CD4 count levels. Results: The non-ART cohort and the ART cohort enrolled 709 and 2 865 HIV-infected individuals, respectively. In untreated individuals, CD4 counts declined progressively: annual transition rates from ≥500 to 350-499, 350-499 to 200-349, and 200-349 to <200 cells/μl were 34.8% (95%CI: 30.3%-39.9%), 19.0% (95%CI: 16.1%-22.5%), and 9.3% (95%CI: 6.8%-12.7%), with mean sojourn times of 2.87, 5.25, and 10.73 years, respectively. After ART initiation, CD4 counts recovery followed a nonlinear pattern: transition rates from <200 to 200-349, 200-349 to 350-499, and 350-499 to ≥500 cells/μl were 91.8% (95%CI: 86.6%-97.4%), 63.7% (95%CI: 60.9%-66.6%), and 42.6% (95%CI: 40.9%-44.4%), with corresponding mean sojourn times of 1.09, 1.57, and 2.35 years. Conclusions: CD4 count transition rates in non-ART HIV-infected individuals decreased as immunodeficiency progressed, while post-ART recovery rates varied substantially across CD4 count strata.

[天津地区抗逆转录病毒初始感染者和抗逆转录病毒治疗感染者队列中CD4+T淋巴细胞计数变化特征]。
目的:了解天津市HIV感染者在未经治疗和抗逆转录病毒治疗(ART)条件下CD4+T淋巴细胞(CD4)计数的动态变化,为优化HIV病例管理和预防策略提供依据。方法:数据来源于中国疾病预防控制信息系统2005 - 2024年天津市15岁及以上hiv感染者的随访记录。记录被分为非抗逆转录病毒治疗阶段和抗逆转录病毒治疗阶段,作为时间依赖的队列,同一艾滋病毒感染者在治疗开始前后的两个阶段都有贡献。连续时间马尔可夫模型应用于两个队列,以估计CD4计数在免疫类别之间的年转换率。此外,将具有自然样条的线性混合效应模型拟合到ART队列中,以基线CD4计数水平分层表征个体恢复轨迹。结果:非抗逆转录病毒治疗组和抗逆转录病毒治疗组分别入组709名和2865名hiv感染者。在未经治疗的个体中,CD4计数逐渐下降:年转换率从≥500到350-499,350-499到200-349和200-349 (CI: 30.3%-39.9%), 19.0% (95%CI: 16.1%-22.5%)和9.3% (95%CI: 6.8%-12.7%),平均逗留时间分别为2.87年,5.25年和10.73年。抗逆转录病毒治疗开始后,CD4计数恢复遵循非线性模式:转换率从CI: 86.6%-97.4%), 63.7% (95%CI: 60.9%-66.6%)和42.6% (95%CI: 40.9%-44.4%),相应的平均停留时间为1.09年,1.57年和2.35年。结论:在非抗逆转录病毒疗法hiv感染者中,CD4计数转换率随着免疫缺陷的进展而下降,而抗逆转录病毒疗法后的恢复率在CD4计数层次上有很大差异。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
中华流行病学杂志
中华流行病学杂志 Medicine-Medicine (all)
CiteScore
5.60
自引率
0.00%
发文量
8981
期刊介绍: Chinese Journal of Epidemiology, established in 1981, is an advanced academic periodical in epidemiology and related disciplines in China, which, according to the principle of integrating theory with practice, mainly reports the major progress in epidemiological research. The columns of the journal include commentary, expert forum, original article, field investigation, disease surveillance, laboratory research, clinical epidemiology, basic theory or method and review, etc.  The journal is included by more than ten major biomedical databases and index systems worldwide, such as been indexed in Scopus, PubMed/MEDLINE, PubMed Central (PMC), Europe PubMed Central, Embase, Chemical Abstract, Chinese Science and Technology Paper and Citation Database (CSTPCD), Chinese core journal essentials overview, Chinese Science Citation Database (CSCD) core database, Chinese Biological Medical Disc (CBMdisc), and Chinese Medical Citation Index (CMCI), etc. It is one of the core academic journals and carefully selected core journals in preventive and basic medicine in China.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书